DE69401661D1 - Nukleinsaeure-analog testverfahren - Google Patents

Nukleinsaeure-analog testverfahren

Info

Publication number
DE69401661D1
DE69401661D1 DE69401661T DE69401661T DE69401661D1 DE 69401661 D1 DE69401661 D1 DE 69401661D1 DE 69401661 T DE69401661 T DE 69401661T DE 69401661 T DE69401661 T DE 69401661T DE 69401661 D1 DE69401661 D1 DE 69401661D1
Authority
DE
Germany
Prior art keywords
nucleic acid
test procedure
acid analog
analog test
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69401661T
Other languages
English (en)
Other versions
DE69401661T2 (de
Inventor
Christopher John Stanley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PNA Diagnostics ApS Denmark
Original Assignee
PNA Diagnostics ApS Denmark
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PNA Diagnostics ApS Denmark filed Critical PNA Diagnostics ApS Denmark
Application granted granted Critical
Publication of DE69401661D1 publication Critical patent/DE69401661D1/de
Publication of DE69401661T2 publication Critical patent/DE69401661T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69401661T 1993-06-02 1994-05-31 Nukleinsaeure-analog testverfahren Expired - Lifetime DE69401661T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939311386A GB9311386D0 (en) 1993-06-02 1993-06-02 Nucleic acid analogue assay procedures
PCT/GB1994/001174 WO1994028171A1 (en) 1993-06-02 1994-05-31 Nucleic acid analogue assay procedures

Publications (2)

Publication Number Publication Date
DE69401661D1 true DE69401661D1 (de) 1997-03-13
DE69401661T2 DE69401661T2 (de) 1997-06-12

Family

ID=10736511

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69401661T Expired - Lifetime DE69401661T2 (de) 1993-06-02 1994-05-31 Nukleinsaeure-analog testverfahren

Country Status (9)

Country Link
US (1) US5912145A (de)
EP (1) EP0701627B1 (de)
JP (1) JP2842694B2 (de)
AU (1) AU6802994A (de)
DE (1) DE69401661T2 (de)
DK (1) DK0701627T3 (de)
ES (1) ES2098948T3 (de)
GB (1) GB9311386D0 (de)
WO (1) WO1994028171A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629178A (en) * 1994-10-28 1997-05-13 Genetics & Ivf Institute Method for enhancing amplification in the polymerase chain reaction employing peptide nucleic acid (PNA)
ATE196322T1 (de) 1995-05-05 2000-09-15 Perkin Elmer Corp Methoden and reagentien fuer die kombination einer pcr-amplifizierung mit einem hybridisierungs-assay
US5939262A (en) 1996-07-03 1999-08-17 Ambion, Inc. Ribonuclease resistant RNA preparation and utilization
US5677124A (en) * 1996-07-03 1997-10-14 Ambion, Inc. Ribonuclease resistant viral RNA standards
US6617422B1 (en) 1997-05-23 2003-09-09 Peter Nielsen Peptide nucleic acid monomers and oligomers
US6485901B1 (en) 1997-10-27 2002-11-26 Boston Probes, Inc. Methods, kits and compositions pertaining to linear beacons
DE60045350D1 (de) 1999-06-01 2011-01-20 Baylor College Medicine Zusammensetzungen und verfahren zur therapeutischen anwendung einer mit dem gen atonal assoziierten sequenz
US6613517B2 (en) * 2000-01-15 2003-09-02 Genelabs Technologies, Inc. Nucleic acid binding assay and selection method
US20030166282A1 (en) 2002-02-01 2003-09-04 David Brown High potency siRNAS for reducing the expression of target genes
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
WO2003064625A2 (en) 2002-02-01 2003-08-07 Sequitur, Inc. Oligonucleotide compositions with enhanced efficiency
US20030211483A1 (en) * 2002-05-09 2003-11-13 Schroeder Benjamin G. Methods for the enrichment of low-abundance polynucleotides
US20060099224A1 (en) 2002-08-12 2006-05-11 David Kirn Methods and compositions concerning poxviruses and cancer
CA2581086C (en) 2004-09-14 2023-11-07 The Regents Of The University Of Colorado, A Body Corporate Method for treatment with bucindolol based on genetic targeting
US8615368B2 (en) 2005-03-10 2013-12-24 Gen-Probe Incorporated Method for determining the amount of an analyte in a sample
US8980246B2 (en) 2005-09-07 2015-03-17 Sillajen Biotherapeutics, Inc. Oncolytic vaccinia virus cancer therapy
JP2009507853A (ja) * 2005-09-07 2009-02-26 ジェンネレックス インコーポレイティッド Ｇｍ−ｃｓｆ発現ポックスウイルスを用いる転移性および／または全身播種性癌の全身処置
JP5346801B2 (ja) 2006-05-12 2013-11-20 セフィード Ｄｎａ組換え接合部の検出
CN105769931B (zh) 2006-09-15 2021-04-27 渥太华医院研究机构 溶瘤弹状病毒
US20100129902A1 (en) 2008-11-24 2010-05-27 Erhard Ralf Schoenbrunner Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
EP2789689B1 (de) 2009-06-29 2016-04-27 Luminex Corporation Chimäre Primer mit Haarnadel-Konformationen und Verfahren zur Verwendung davon
US9409983B2 (en) 2009-07-23 2016-08-09 The Board Of Trustess Of The University Of Illinois Methods and compositions involving PBEF inhibitors for lung inflammation conditions and diseases
US9512481B2 (en) 2009-09-11 2016-12-06 The Regents Of The University Of Colorado, A Body Corporate Polymorphisms in the PDE3A gene
KR101759888B1 (ko) 2009-09-14 2017-07-20 신라젠(주) 종양 용해 백시니아 바이러스 병용 암 치료요법
AU2010329551B2 (en) 2009-12-10 2016-02-11 Turnstone Limited Partnership Oncolytic rhabdovirus
DK2515899T3 (en) 2009-12-23 2016-08-15 Arca Biopharma Inc METHODS AND COMPOSITIONS FOR CARDIOVASCULAR DISEASES AND CONDITIONS
CN103429258B (zh) 2011-01-04 2016-03-09 新罗杰公司 通过施用溶瘤痘苗病毒生成针对肿瘤抗原的抗体和生成肿瘤特异性补体依赖性细胞毒性
US20140057295A1 (en) 2011-02-28 2014-02-27 Barbara J. Stegmann Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender
CA2829300A1 (en) 2011-03-08 2012-09-13 King Abdullah University Of Science And Technology Molecular biomarker set for early detection of ovarian cancer
WO2012167382A1 (en) 2011-06-08 2012-12-13 Children's Hospital Of Eastern Ontario Research Institute Inc. Compositions and methods for glioblastoma treatment
WO2013036799A2 (en) 2011-09-09 2013-03-14 Fred Hutchinson Cancer Research Center Methods and compositions involving nkg2d inhibitors and cancer
WO2014116721A1 (en) 2013-01-22 2014-07-31 The Arizona Board Of Regents For And On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
CN105658790A (zh) 2013-02-21 2016-06-08 东安大略研究所儿童医院有限公司 疫苗组合物
AU2014329535B2 (en) 2013-10-03 2017-09-07 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
CA2936467A1 (en) 2014-01-10 2015-07-16 Glaxosmithkline Intellectual Property (No.2) Limited Hydroxy formamide derivatives and their use
GB201411567D0 (en) * 2014-06-30 2014-08-13 Epistem Ltd Quantification methods
US20180057839A1 (en) 2014-11-26 2018-03-01 The Regents Of The University Of California Therapeutic compositions comprising transcription factors and methods of making and using the same
WO2018140606A1 (en) 2017-01-26 2018-08-02 Oklahoma Medical Research Foundation Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
CN113196059A (zh) 2018-10-18 2021-07-30 俄克拉荷马医学研究基金会 表征疾病活动性的系统性红斑狼疮(sle)疾病活动性免疫指数的生物标志物
US11733242B2 (en) 2018-10-31 2023-08-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Biomarkers and methods of use for radiation-induced lung injury

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219727A (en) * 1989-08-21 1993-06-15 Hoffmann-Laroche Inc. Quantitation of nucleic acids using the polymerase chain reaction
GB9016163D0 (en) * 1990-07-24 1990-09-05 Cemu Bioteknik Chemical method
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
GB9211979D0 (en) * 1992-06-05 1992-07-15 Buchard Ole Uses of nucleic acid analogues

Also Published As

Publication number Publication date
US5912145A (en) 1999-06-15
AU6802994A (en) 1994-12-20
WO1994028171A1 (en) 1994-12-08
DE69401661T2 (de) 1997-06-12
EP0701627B1 (de) 1997-01-29
ES2098948T3 (es) 1997-05-01
JPH08510384A (ja) 1996-11-05
DK0701627T3 (da) 1997-07-21
EP0701627A1 (de) 1996-03-20
JP2842694B2 (ja) 1999-01-06
GB9311386D0 (en) 1993-07-21

Similar Documents

Publication Publication Date Title
DE69401661D1 (de) Nukleinsaeure-analog testverfahren
DE69635744D1 (de) Modifizierte Nukleinsäuresonden
DE69841895D1 (de) Nukleinsäuretestverfahren
DE69416200D1 (de) Sondenkonstruktion
ATE230981T1 (de) Verfahren
DE69431317D1 (de) DNS-Analyse Verfahren
DE69404652D1 (de) Analysegerät
DK79793D0 (da) Diagnostic test
DE69431229D1 (de) Analoges mehrkanaliges Prüfsystem
DK0623580T3 (da) 2-Keto-3-methyl-4-hydroxy-valerianesyre
DE69406945D1 (de) Katalytisches verfahren
FI964657A (fi) Geenitestausmenetelmä
NO962493D0 (no) Skumdemper-testapparat
DE59402621D1 (de) Fluor-trifluormethylbenzoesäure-Derivate
DE69417423D1 (de) Sondenmikroskopie
FI973639A (fi) Testausastia
DE59405241D1 (de) Sauerstoffmessfühler
DE69405158D1 (de) Elektrotauchlack
DE59406694D1 (de) Viruswirksame substanzen
BR9407815A (pt) Método de ensaio
DE59407860D1 (de) Prüfgerät
KR950001267U (ko) 전기핵산유출기
NO942034D0 (no) Testapparat
DE59408411D1 (de) Testbesteck
KR950012295U (ko) 프로브의 구조

Legal Events

Date Code Title Description
8364 No opposition during term of opposition